Using red blood cell indices for hemoglobin H disease screening in neonates with early neonatal jaundice
Keywords:
HbH disease, red blood cell indices, early neonatal jaundiceAbstract
Objective: The diagnostic research aimed to determine the predictive values of red blood cell indices for screening HbH in neonates with early neonatal jaundice. The red blood cell indices consisted of MCV, MCH, and MCHC.
Materials and Methods: The purposive samples were neonates with early neonatal jaundice receiving phototherapy at Queen Savang Vadhana Memorial Hospital from October 2019 to October 2020. These neonates were divided into four groups according to their hemoglobin typing as followed; 1) neonates with normal hemoglobin typing for age, 2) neonates with HbH disease (Hb Barts>25% or presence of HbH at birth), 3) neonates with Hb Barts between 1-25%, and 4) neonates with other abnormal hemoglobin typing e.g.Hemoglobin E. Descriptive statistics were frequency, percentages, mean and standard deviation. Chi-square test and one-way analysis of variance were used to compare the percentages and mean among the four groups. Unpaired t-test was used to compare mean and standard deviation between two independent groups. Univariate analysis was used to analyze risk ratio with 95% confidence interval (95%CI) in various values of red blood cell indices for predicting HbH. Sensitivity, specificity, accuracy, positive and negative predictive values were calculated at various values of red blood cell indices to predict HbH diseases. The statistical significance was considered as P value less than 0.05.
Results: Five hundred and four neonates were enrolled, of whom six were affected by HbH disease. The incidence rate of HbH disease was 11.9 per 1000 live births. The demographic and clinical characteristics including sex, body weight, gestational age, age at admission and route of delivery among the four groups were not different. As compared to the other groups, the HbH group had the lowest significance for MCV, MCH, and MCHC (p<0.05). The strongest cut-off points of red blood cell indices that suggest the risk for HbH disease were MCH<27 pg combined with MCHC<32 mg/dL. The risk ratio was 355.0 (95% CI=47.4-2658.1) when compared with MCH>27 pg and MCHC>32 mg/dL. Additionally, the MCH<27 pg combined with MCHC<32 mg/dL had sensitivity and specificity at 0.71 and 1.00, respectively. Its accuracy, positive and negative predictive values were 0.99, 0.71, and 1.00, respectively.
Conclusion: This study suggested that hemoglobin typing should be performed in neonates with early neonatal jaundice who had MCH<27 pg and MCHC<32 mg/dL.
Downloads
References
Jardine LA, Woodgate P. Neonatal jaundice. American Family Physicin. 2012;85:824-5.
Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: type, causes, clinical examinations, preventive measures and treatments: a narrative review article. Iran J Public Health. 2016;45(5):558-68.
Morioka I, Morikawa S, Yusoff S, Indra Sari Kusuma Harahap, Nishimura N. Genetics disorders with neonatal jaundice. Eastern Journal of Medicine. 2010;15:155-62.
คณะกรรมการจัดทำคู่มือปฏิบัติงานการตรวจและวินิจฉัยโรคธาลัสซีเมียและฮีโมโกลบินผิดปกติทางห้องปฏิบัติการ.คู่มือทางห้องปฏิบัติการตรวจวินิจ
ฉัยธาลัสซีเมียและฮีโมโกลบินผิดปกติ. กรุงเทพ;ศูนย์วิจัยทางคลินิก กรมวิทยาศาสตร์การแพทย์ กระทรวงสาธารณสุข สำนักพิมพ์บริษัท หมัดเด็ดพิมพ์ครั้งที่5:2556.
Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematology Education
Program 2009;26-34.
ณรงค์วิทย์ตริสกุล, พงศธร ศิริพูลศักดิ์, วิภาดา เชื้อศุภโลบล.ความชุกของธาลัสซีเมียฮีโมโกลบิน ผิดปกติจำ นวนคู่เสี่ยง.วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต 2552;19:285-92.
Wanapirak C, Muninthorn W, Sanguansermsri T, Dhananjayanonda P, Tongsong T. Prevalence of Thalassemia in Pregnant Woman at Maharaj NakornChaingMai Hospital. J Med Assoc Thai. 2004;87:1415-18.
. Fucharoen S, Winichagoon P. Haemoglobinopathies inSoutheast Asia. Indian J Med Res. 2011;134:498–506.
Lanxkovsky P, Lipton JM, FishJ D. Lanzkowsky’s manual o f pediatrics hematology and oncology,6th edition;2016:P185.
Xie XM, Zhou JY, LiJ, Li R, Liou C, Li DZ. Implementation of Newborn Screening for Hemoglobin H in Mainland China. Indian J Hematol blood transfuse. 2015;31:242–6.
MuellerB,KalpatthiR. abnormal hemoglobin Screening in newborn, What now? Focus on subspecialties. AAP news 2011; 32(5):12.
Keren DF, Hedstrom D, Gulbranson R. Comparison of Sebia Capillarys Capillary Electrophoresis with the Primus High Pressure Liquid Chromatography in the Evaluation of Hemoglobinopathies. Am J Clin Pathol 2008;130:824-31.
Rugless MJ, Fisher CA, Stephens AD, Amos RJ, Mohammed T, Old JM. Hb Bart’s in Cord Blood: An Accurate Indicator of
α-Thalassemia. Hemoglobin 2006;30:57-62.
Munkongdee T,Pichanun D. Butthep. Quantitative analysis of Hb Bart’s in cord blood by capillary electrophoresis system. Ann Hematol 2011;90:741-6.
Jaruchareonporn S. Newborn Screening for thalassemia and hemoglobinopathies In a community hospital. วารสารกรมการแพทย์
;153-9.
Uaprasert N, Settapiboon R, Amornsiriwat S. Diagnosisutility of isoelectric focusing and high performance liquidchromatography in
neonatal cord blood sampling forthalassemia and non-sickling hemoglobinopathies. ClinChim Acta 2014;427:23-6
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.